4
Changes in Ownership
Natera, Inc. Filed Acc 0001415889-25-010103
PRESIDENT, CLINICALDIAGNOSTICS sold 3,000 shares at an average $140.48 ($421,428)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-01 | Sale : show line 1 in the form 10b5-1 | −1,291 | $139.78 | $180,450 | 143,491 | D |
| 2025-04-01 | Sale : show line 2 in the form 10b5-1 | −1,270 | $140.70 | $178,684 | 142,221 | D |
| 2025-04-01 | Sale : show line 3 in the form 10b5-1 | −439 | $141.90 | $62,294 | 141,782 | D |
| Open-market sales · 3,000 sh · avg $140.48 · $421,428 | ||||||
Loading xslF345X05/form4-04032025_080401.xml…